An international team led by Monash University and Baylor College of Medicine, Texas, has found “switching off” an enzyme called CaMKK2 in immune cells that drive inflammation prevents diet-induced obesity, diabetes and fatty liver disease.
This article was originally published on MedicalXpress.com